Almirall Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs

DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Almirall - Digital Transformation Strategies" company profile has been added to  ResearchAndMarkets.com's offering.

This report provides insights into Almirall's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Almirall is a global biopharmaceutical company specializing in dermatology. The company develops and commercializes solutions for the treatment of a variety of dermatological diseases such as acne, atopic dermatitis, actinic keratosis, and psoriasis among others.

Some of the company's key products are Ilumetri (for moderate-to-severe plaque psoriasis), Wynora cream (for mild-to-moderate plaque psoriasis), Skilarence (for moderate-to-severe plaque psoriasis), Seysara (for acne), Ciclopoli (for onychomycosis), and Klisyri, Actikerall, and Solaraze (for actinic keratosis).

The company also produces medicines for the neurological, gastric, and cardiac diseases. The company's key dermatological products have been used by 324,000 people since their launches.

Scope

• Almirall is leveraging several emerging technologies to quickly discover drugs, drive sales, streamline production, expand market presence and help patients recover quickly. Cloud, AI, and digital therapeutics are among the technologies the company is focusing on.
• Almirall launched its dermatology digital health accelerator, Digital Garden, in 2020 to support startups that are focused on developing technology-based services and solutions for various dermatological diseases.
• In 2023, Almirall partnered with NTT Data to accelerate the process of extracting information from medical papers.

Reasons to Buy

• Gain insights into Almirall's technology initiatives.
• Gain insights into its digital strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into its various technology launches and partnerships.

Key Topics Covered:

• Overview
• Digital Transformation Strategy
• Accelerators, Incubators, and Other Innovation Programs
• Technology Focus
• Technology Initiatives
• Partnership Network Map
• ICT Budget and Contracts
• Key Executives

A selection of companies mentioned in this report includes

• NTT Data
• ZeClinics
• Iktos
• Clariba

For more information about this company profile visit https://www.researchandmarkets.com/r/mi4ang

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/almirall-digital-transformation-strategy-analysis-report-2023-accelerators-incubators-and-other-innovation-programs-302031686.html

SOURCE Research and Markets